Page last updated: 2024-10-31

mitotane and Genetic Predisposition

mitotane has been researched along with Genetic Predisposition in 3 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Research Excerpts

ExcerptRelevanceReference
"Adrenocortical carcinomas are rare in children and sometimes occur in patients with predisposing syndrome like Li-Fraumeni or Beckwith-Wiedemann syndromes."2.47[Management of adrenocortical carcinomas in children]. ( Aubert, S; Delebarre, M; Leblond, P, 2011)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Patalano, A1
Brancato, V1
Mantero, F1
Wandoloski, M1
Bussey, KJ1
Demeure, MJ1
Leblond, P1
Delebarre, M1
Aubert, S1

Reviews

3 reviews available for mitotane and Genetic Predisposition

ArticleYear
Adrenocortical cancer treatment.
    Hormone research, 2009, Volume: 71 Suppl 1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Algorithms; Antineoplastic Combined Chemotherapy

2009
Adrenocortical cancer.
    The Surgical clinics of North America, 2009, Volume: 89, Issue:5

    Topics: Adrenal Cortex Neoplasms; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Diagnosis, Dif

2009
[Management of adrenocortical carcinomas in children].
    Bulletin du cancer, 2011, Volume: 98, Issue:5

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Beckwith-Wiedem

2011